ELAB Eon Labs
Eon Labs, Inc. is a generic pharmaceutical company engaged in developing, licensing, manufacturing, selling and distributing prescription pharmaceutical products. For the 9 months ended 9/30/04, revenues rose 37% to $321M. Net income rose 75% to $89.2M. Revenues reflect sales growth due to the introduction of new products. Net income also reflects the absence of a $300K interest expenses and improved gross profit margins.
Financials & Ratios
Book Value/Share ($) 4.65
Cash Per Share ($) 2.41
Current Ratio (MRQ) 3.13
Div/Yield % NA
Earn/Shr ($) 1.20
Ex-Div Amt. ($) NA
Ex-Div Date NA
Float¹ 28.40
Market Cap¹ 2,217.03
P/E (TTM) 20.89
Price/Book (MRQ) 5.37
Price/Cash Flow (TTM) 19.07
Price/Revenue (TTM) 5.44
ROA (TTM) 22.78
ROE (TTM) 30.20
Shares Out¹ 88.82
Total Debt/Equity (MRQ) 0.00
6 MONATE
3 JAHRE